लोड हो रहा है...
Anaplastic Lymphoma Kinase (ALK) as a therapeutic target in non-small cell lung cancer
The therapeutic targeting of anaplastic lymphoma kinase (ALK) has been a burgeoning area of research since 2007 when ALK fusions were initially identified in patients with non-small cell lung cancer (NSCLC). The field has rapidly progressed through development of the first-generation ALK inhibitor,...
में बचाया:
| में प्रकाशित: | Cancer J |
|---|---|
| मुख्य लेखकों: | , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2015
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5242382/ https://ncbi.nlm.nih.gov/pubmed/26389762 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000142 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|